Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer

Published:2013-11-23 Issue:5 Volume:19 Page:946-954
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Matsuyama Hideyasu,Shimabukuro Tomoyuki,Hara Isao,Kohjimoto Yasuo,Suzuki Kazuhiro,Koike Hidekazu,Uemura Hirotsugu,Hayashi Taiji,Ueno Munehisa,Kodaira Kiichiro,Tomita Yoshihiko,Sakurai Toshihiko,Shimizu Nobuaki

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-013-0638-2.pdf

Reference23 articles.

1. Ohshima A, Kuroishi T, Tajima K (2004) Cancer statistics white paper disease/death/prognosis 2004. Shinoharashinsha, Tokyo, pp 201–217, 220–234

2. Tannock IF, de Wit R, Berry WR et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502–1512

3. Berthold DR, Pond GR, Soban F et al (2008) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol 26:242–245

4. Petrylak DP, Tangen CM, Hussain MH et al (2004) Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351:1513–1520

5. de Bono JS, Logothetis CJ, Molina A et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995–2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OVERALL SURVIVAL EVALUATION OF PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY BY ESTIMATING FLUCTUANT PATTERNS OF METABOLIC FACTOR SERUM LEVELS;The Japanese Journal of Urology;2022-01-20

2. The Role of C-Reactive Protein in Kidney, Bladder, and Prostate Cancers;Frontiers in Immunology;2021-08-27

3. Development and validation of risk and prognostic nomograms for bone metastases in Chinese advanced colorectal cancer patients;Annals of Translational Medicine;2021-05

4. ADVERSE EFFECTS OF ANDROGEN DEPRIVATION THERAPY ON PATIENTS WITH PROSTATE CANCER AND ITS EFFECT ON OVERALL SURVIVAL;The Japanese Journal of Urology;2021-04-20

5. Can conventional clinical chemistry tests help doctors in the monitoring of oncology patients?;Russian Open Medical Journal;2021-03-30